Clinical Trials Logo

Keratitis clinical trials

View clinical trials related to Keratitis.

Filter by:

NCT ID: NCT01739673 Completed - Clinical trials for Infectious Keratitis

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Start date: August 2011
Phase: N/A
Study type: Interventional

This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.

NCT ID: NCT01721694 Withdrawn - Keratitis Clinical Trials

Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection

Start date: December 2012
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of fixed combination of azithromycin 1.5% + 0.5% Loteprednol eye drops for the treatment of ocular inflammation and infection associated bacterial blepharitis and / or keratitis and / or conjunctivitis compared with the individual administration of azithromycin 1.5% and 0.5% Loteprednol (separately).

NCT ID: NCT01560208 Recruiting - Corneal Ulcer Clinical Trials

The Asia Cornea Society Infectious Keratitis Study

ACSIKS
Start date: April 2012
Phase: N/A
Study type: Observational

Corneal diseases are a major cause of blindness worldwide, and corneal infections are a substantial cause of blindness in Asia. The aim of the Asia Cornea Society Infectious Keratitis Study (ACSIKS) is to study infectious keratitis (corneal infections) in Asian countries, so as to improve strategies for prevention and treatment, and to reduce the burden of blindness in Asia. The first phase of ACSIKS is an 18-month observational study involving 11 eye hospitals in 8 Asian countries; these hospitals manage more than 6700 cases of corneal infections every year. From the first quarter of 2012, all patients with a corneal infection will be recruited and a standard ACSIKS protocol will be applied; this protocol includes the use of a common set of study forms and a suggested panel of microbiological examinations. However, each centre will be continue to treat their patients with the anti-infective therapy standard for their centre. Data will be recorded for each patient for a period of six months, including their medical and surgical management, the final clinical outcome and vision. Bacterial and fungal growths from patients will also be stored for further research during a second phase of ACSIKS. These studies will focus on evaluating the resistance of the most common bacterial infections to the current available antibiotics, performing DNA testing to compare our strains with bacterial infections in the West, and to developing new diagnostic tests and anti-infective therapies tailored to corneal infections in Asia.

NCT ID: NCT01437319 Completed - Clinical trials for Corneal Inflammation

Mucin Balls and Corneal Inflammation Events

Start date: September 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if the formation of mucin balls is a marker for protection from inflammatory events to the cornea and if mucin balls play a role in protection during extended contact lens wear.

NCT ID: NCT01272271 Completed - Myopia Clinical Trials

Safety of Overnight Corneal Reshaping Lenses

Start date: February 2008
Phase:
Study type: Observational

This retrospective chart review study compares the incidence of corneal inflammation due to infection in children vs. adult patients wearing overnight corneal reshaping lenses.

NCT ID: NCT01268306 Completed - Keratitis Clinical Trials

Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses

Start date: October 2010
Phase: Phase 4
Study type: Interventional

Corneal epithelial disruption, commonly termed "corneal staining" has been frequently associated with contact lens wear. Previous research has demonstrated higher levels of observed corneal staining when certain combinations of contact lenses and lens care products are used, particularly under daily wear regimens. B+L lenses made from Balafilcon (PureVision) have been associated with the highest rates of observed staining. Additionally, polyhexamethylene biguanide (PHMB) based lens care products, specifically B+L ReNu MultiPlus have been implicated in higher rates of staining. In general, many lenses constructed from newer, silicone hydrogel (SiHy) materials appear more susceptible to increased rates and amounts of corneal staining. Although the clinical significance of staining is debated, most clinicians agree that less staining is preferable to greater amounts of staining. Advances in understanding as well as the specifics of lens care product formulation ideally will have resulted in design of newer products that minimize corneal staining and maximize product performance. This study will examine rates of corneal staining using B+L's recently introduced lens care product: BioTrue with the B+L PureVision lens which has previously been associated with the highest levels of staining.

NCT ID: NCT01028027 Completed - Blepharitis Clinical Trials

Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis

Start date: October 2009
Phase: Phase 3
Study type: Interventional

This study is to evaluate the safety and efficacy of loteprednol etabonate [LE] and tobramycin ophthalmic suspension versus tobramycin and dexamethasone ophthalmic suspension in the treatment of ocular inflammation associated with blepharokeratoconjunctivitis (BKC).

NCT ID: NCT00949468 Completed - Keratitis Clinical Trials

Microbiological Keratitis in a Countryside City of Brazil

Start date: June 2008
Phase: N/A
Study type: Observational

The purpose of this study is to identify the predisposing factors, epidemiological features and clinical and microbiological diagnosis of infectious keratitis in two public referral centers of ophthalmology in a countryside city of Brazil.

NCT ID: NCT00912509 Terminated - Clinical trials for Infectious Keratitis

Cross Linking for Treatment of Corneal Infection

Start date: May 2009
Phase: N/A
Study type: Interventional

This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.

NCT ID: NCT00838422 Recruiting - Keratitis Clinical Trials

Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound

Start date: June 2008
Phase: N/A
Study type: Observational

The purpose of this study is to assess the repeatability, reproducibility, and agreement of central corneal thickness measured by Fourier Domain Optical Coherence tomography (FD-OCT, OptoVue, USA) with anterior corneal module, 20MHz ultrasound pachymetry equipped with Ocular response analyzer (ORA, Reichert Ophthalmic Instruments, USA) and 10MHz Ultrasound Pachymetry (USP).